aica ribonucleotide and Mesothelioma

aica ribonucleotide has been researched along with Mesothelioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heyer, CL; Moran, RG; Racanelli, AC; Rothbart, SB	1

Other Studies

1 other study(ies) available for aica ribonucleotide and Mesothelioma

Article	Year
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition. Cancer research, 2009, Jul-01, Volume: 69, Issue:13 Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Division; Enzyme Activation; Folic Acid Antagonists; Glutamates; Glycine; Guanine; Humans; Kinetics; Lung Neoplasms; Mesothelioma; Pemetrexed; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinases; Ribonucleotides; TOR Serine-Threonine Kinases	2009

Article

Year

Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.

Cancer research, 2009, Jul-01, Volume: 69, Issue:13

Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Division; Enzyme Activation; Folic Acid Antagonists; Glutamates; Glycine; Guanine; Humans; Kinetics; Lung Neoplasms; Mesothelioma; Pemetrexed; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinases; Ribonucleotides; TOR Serine-Threonine Kinases

2009